| # | Title | Journal | Year | Citations |
|---|
|
| 1 | A review of MRI findings in schizophrenia | Schizophrenia Research | 2001 | 2,163 |
| 2 | The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery | Schizophrenia Research | 2004 | 1,263 |
| 3 | Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS | Schizophrenia Research | 2004 | 1,230 |
| 4 | Schizophrenia, symptomatology and social inference: Investigating “theory of mind” in people with schizophrenia | Schizophrenia Research | 1995 | 1,147 |
| 5 | What does the PANSS mean? | Schizophrenia Research | 2005 | 1,116 |
| 6 | A depression rating scale for schizophrenics | Schizophrenia Research | 1990 | 1,109 |
| 7 | Identification of separable cognitive factors in schizophrenia | Schizophrenia Research | 2004 | 1,109 |
| 8 | A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors | Schizophrenia Research | 2005 | 1,087 |
| 9 | Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III | Schizophrenia Research | 2005 | 1,022 |
| 10 | Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group | Schizophrenia Research | 2003 | 993 |
| 11 | Strauss (1969) revisited: a psychosis continuum in the general population? | Schizophrenia Research | 2000 | 816 |
| 12 | Schizophrenia, “just the facts” 4. Clinical features and conceptualization | Schizophrenia Research | 2009 | 816 |
| 13 | The disconnection hypothesis | Schizophrenia Research | 1998 | 803 |
| 14 | Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials | Schizophrenia Research | 1999 | 783 |
| 15 | Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses | Schizophrenia Research | 2000 | 716 |
| 16 | Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia | Schizophrenia Research | 2012 | 686 |
| 17 | Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure | Schizophrenia Research | 2007 | 684 |
| 18 | Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features | Schizophrenia Research | 2004 | 680 |
| 19 | A new instrument for measuring insight: the Beck Cognitive Insight Scale | Schizophrenia Research | 2004 | 669 |
| 20 | Meta-analysis of diffusion tensor imaging studies in schizophrenia | Schizophrenia Research | 2009 | 662 |
| 21 | Theory of mind impairment in schizophrenia: Meta-analysis | Schizophrenia Research | 2009 | 653 |
| 22 | Mismatch negativity in schizophrenia: a meta-analysis | Schizophrenia Research | 2005 | 648 |
| 23 | Decreased volume of left and total anterior insular lobule in schizophrenia | Schizophrenia Research | 2006 | 635 |
| 24 | Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology | Schizophrenia Research | 2008 | 619 |
| 25 | Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings | Schizophrenia Research | 2003 | 618 |
| 26 | Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium | Schizophrenia Research | 2004 | 604 |
| 27 | Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis | Schizophrenia Research | 2010 | 585 |
| 28 | Seasonality of births in schizophrenia and bipolar disorder: a review of the literature | Schizophrenia Research | 1997 | 582 |
| 29 | Reliability and validity of a depression rating scale for schizophrenics | Schizophrenia Research | 1992 | 577 |
| 30 | Mortality and causes of death in schizophrenia in Stockholm County, Sweden | Schizophrenia Research | 2000 | 553 |
| 31 | The Stanley Foundation brain collection and Neuropathology Consortium | Schizophrenia Research | 2000 | 527 |
| 32 | IRAOS: an instrument for the assessment of onset and early course of schizophrenia | Schizophrenia Research | 1992 | 525 |
| 33 | Definition and description of schizophrenia in the DSM-5 | Schizophrenia Research | 2013 | 522 |
| 34 | Insight in schizophrenia: a meta-analysis | Schizophrenia Research | 2003 | 515 |
| 35 | Meta-analysis of the P300 and P50 waveforms in schizophrenia | Schizophrenia Research | 2004 | 515 |
| 36 | Anatomy of bipolar disorder and schizophrenia: A meta-analysis | Schizophrenia Research | 2010 | 508 |
| 37 | The global cognitive impairment in schizophrenia: Consistent over decades and around the world | Schizophrenia Research | 2013 | 490 |
| 38 | Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline | Schizophrenia Research | 2006 | 479 |
| 39 | Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground | Schizophrenia Research | 1995 | 478 |
| 40 | The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model | Schizophrenia Research | 2006 | 477 |
| 41 | Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: A meta-analysis | Schizophrenia Research | 2009 | 477 |
| 42 | Psychotic symptoms in non-clinical populations and the continuum of psychosis | Schizophrenia Research | 2002 | 473 |
| 43 | A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls | Schizophrenia Research | 2005 | 471 |
| 44 | The dysconnection hypothesis (2016) | Schizophrenia Research | 2016 | 459 |
| 45 | Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials | Schizophrenia Research | 2003 | 451 |
| 46 | From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis | Schizophrenia Research | 2005 | 445 |
| 47 | A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder | Schizophrenia Research | 2004 | 443 |
| 48 | Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes | Schizophrenia Research | 1999 | 436 |
| 49 | Amplitude of low-frequency oscillations in schizophrenia: A resting state fMRI study | Schizophrenia Research | 2010 | 430 |
| 50 | Self-stigma, empowerment and perceived discrimination among people with schizophrenia in 14 European countries: The GAMIAN-Europe study | Schizophrenia Research | 2010 | 429 |
